Related Experiment Videos
A model-based approach to estimate the AIDS-free time distribution in homosexual men using longitudinal data
D D Dunlop1, A C Tamhane, J S Chmiel
1Center for Health Services and Policy Research, Northwestern University, Evanston, Illinois 60208.
Journal of Biopharmaceutical Statistics
|July 1, 1994
Summary
This study models time to acquired immunodeficiency syndrome (AIDS) diagnosis using human immunodeficiency virus (HIV) infection markers. The discrete hazard rate model identifies key predictors for estimating AIDS-free survival distributions.
Area of Science:
- Biostatistics
- Epidemiology
- Mathematical Modeling
Background:
- Estimating time from human immunodeficiency virus (HIV) seroconversion to acquired immunodeficiency syndrome (AIDS) diagnosis is crucial for understanding disease progression.
- Longitudinal data from HIV-positive individuals presents challenges due to interval-censored seroconversion times and right-censored endpoints.
Purpose of the Study:
- To develop and apply a model-based approach for estimating the time from HIV seroconversion to AIDS diagnosis.
- To identify time-dependent covariates that influence the progression from HIV infection to AIDS.
Main Methods:
- A discrete hazard rate (DHR) model, a generalized linear model with a complementary log-log link, was proposed for interval-censored data.
- Classification trees were used for covariate screening, and imputation was employed for missing seroconversion times.
- Maximum-likelihood estimation and the jackknife procedure were used for parameter estimation and precision assessment.
Main Results:
- The final DHR model incorporated CD4% count, hemoglobin levels, p24 antigen presence, and their interaction as significant predictors of AIDS progression.
- The model successfully estimated the discrete survival distribution of AIDS-free time for the studied cohort.
Conclusions:
- The developed DHR model provides a robust method for analyzing time-to-AIDS in HIV-infected individuals with complex data censoring.
- Key infection progression markers significantly influence the rate of AIDS development, aiding in prognosis and clinical management.